SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-024726
Filing Date
2023-07-17
Accepted
2023-07-17 16:15:16
Documents
15
Period of Report
2023-07-11
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40664
2 ex16-1.htm EX-16.1 5595
3 ex16-1_001.jpg GRAPHIC 3813
4 ex16-1_002.jpg GRAPHIC 12832
  Complete submission text file 0001493152-23-024726.txt   241196

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE eltp-20230711.xsd EX-101.SCH 3024
6 XBRL LABEL FILE eltp-20230711_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE eltp-20230711_pre.xml EX-101.PRE 22365
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3128
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 231091771
SIC: 2834 Pharmaceutical Preparations